Trophos Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$532M
Trophos General Information
Description
Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological and cardiac diseases. The company involves screening chemical collections of small molecules on models of sick neurons, using the class of neurons affected in each type of disease.
Contact Information
Website
www.trophos.comCorporate Office
- Parc scientifique de Luminy
- Cedex 9, Case 931
- 13288 Marseille
- France
Corporate Office
- Parc scientifique de Luminy
- Cedex 9, Case 931
- 13288 Marseille
- France
Trophos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 03-Mar-2015 | $532M | Completed | Generating Revenue | ||
| 7. Grant | 11-Oct-2012 | Completed | Generating Revenue | |||
| 6. Grant | 26-Mar-2009 | Completed | Generating Revenue | |||
| 5. Grant | 23-Dec-2008 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 04-Sep-2007 | Completed | Generating Revenue | |||
| 3. Grant | 04-Sep-2007 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Apr-2003 | $6.91M | $22.6M | Completed | Startup | |
| 1. Early Stage VC | $15.7M | $15.7M | Completed | Startup |
Trophos Comparisons
Industry
Financing
Details
Trophos Competitors (84)
One of Trophos’s 84 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Vivus | Corporate Backed or Acquired | Campbell, CA | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom |
Trophos Patents
Trophos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2747750-A2 | Liposome comprising at least a cholesterol derivative | Inactive | 25-Aug-2011 | ||
| AU-2013203682-A1 | Liposome comprising at least one cholesterol derivative | Active | 25-Aug-2011 | ||
| AU-2013203682-B2 | Liposome comprising at least one cholesterol derivative | Inactive | 25-Aug-2011 | ||
| CA-2845691-A1 | Liposome comprising at least one cholesterol derivative | Inactive | 25-Aug-2011 | ||
| FR-2979239-A1 | Liposome comprising at least one cholesterol derivative | Pending | 25-Aug-2011 | A61K31/575 |
Trophos Signals
Trophos Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amundi Private Equity Funds | PE/Buyout | Minority | ||
| Apicap | PE/Buyout | Minority | ||
| Arch Capital Group | Corporation | Minority | ||
| Crédit Mutuel Impact | Asset Manager | Minority | ||
| Genethon Cure Through Innovation | Corporation | Minority |
Trophos FAQs
-
When was Trophos founded?
Trophos was founded in 1999.
-
Where is Trophos headquartered?
Trophos is headquartered in Marseille, France.
-
What is the size of Trophos?
Trophos has 17 total employees.
-
What industry is Trophos in?
Trophos’s primary industry is Drug Discovery.
-
Is Trophos a private or public company?
Trophos is a Private company.
-
What is the current valuation of Trophos?
The current valuation of Trophos is .
-
What is Trophos’s current revenue?
The current revenue for Trophos is .
-
How much funding has Trophos raised over time?
Trophos has raised $34.2M.
-
Who are Trophos’s investors?
Amundi Private Equity Funds, Apicap, Arch Capital Group, Crédit Mutuel Impact, and Genethon Cure Through Innovation are 5 of 11 investors who have invested in Trophos.
-
Who are Trophos’s competitors?
Inovio Pharmaceuticals, Vivus, Sarepta Therapeutics, Fate Therapeutics, and Immunocore Holdings are some of the 84 competitors of Trophos.
-
When was Trophos acquired?
Trophos was acquired on 03-Mar-2015.
-
Who acquired Trophos?
Trophos was acquired by Roche.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process